About Protembis
Protembis is a company based in Aachen (Germany) founded in 2013 by Karl Von Mangoldt.. Protembis has raised $45.17 million across 5 funding rounds from investors including Abiomed, European Investment Bank and BMBF. Protembis offers products and services including ProtEmbo Cerebral Protection System. Protembis operates in a competitive market with competitors including Claret Medical, Emboline, Synaptive Medical, Filterlex Medical and Keystone Heart, among others.
- Headquarter Aachen, Germany
- Founders Karl Von Mangoldt
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Protembis Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$45.17 M (USD)
in 5 rounds
-
Latest Funding Round
$21.67 M (USD), Debt – Venture
Jul 30, 2024
-
Investors
Abiomed
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Protembis
Protembis offers a comprehensive portfolio of products and services, including ProtEmbo Cerebral Protection System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Protects brain from injury during TAVR procedures effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Protembis
Protembis has successfully raised a total of $45.17M across 5 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $21.67 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Venture — $21.7M
- First Round First Round
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Debt – Venture - Protembis | Valuation |
investors |
|
| Mar, 2024 | Amount | Series B - Protembis | Valuation | Segulah Medical Acceleration , XGEN Venture | |
| Oct, 2018 | Amount | Series A - Protembis | Valuation | Abiomed , Coparion |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Protembis
Protembis has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Abiomed, European Investment Bank and BMBF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Early stage investments in life sciences are facilitated by XGEN Venture.
|
Founded Year | Domain | Location | |
|
TechVision Fonds is engaged in early-stage venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Protembis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Protembis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Protembis Comparisons
Competitors of Protembis
Protembis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claret Medical, Emboline, Synaptive Medical, Filterlex Medical and Keystone Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cerebral vascular protection systems for endovascular procedures are developed.
|
|
| domain | founded_year | HQ Location |
Aortic embolic protection devices are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Planning and imaging solutions for neurosurgery are developed.
|
|
| domain | founded_year | HQ Location |
Developer of an embolic protection device
|
|
| domain | founded_year | HQ Location |
Embolic cerebral protection devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Protembis
Frequently Asked Questions about Protembis
When was Protembis founded?
Protembis was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Protembis located?
Protembis is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.
Is Protembis a funded company?
Protembis is a funded company, having raised a total of $45.17M across 5 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Apr 24, 2015.
What does Protembis do?
Protembis was founded in 2013 and is based in Aachen, Germany. Operations are centered in the medical device sector, where an implantable filter system is produced for use during minimally invasive cardiac surgeries involving the left heart. The device is introduced into the aortic arch to block embolic particles from reaching the cerebral vasculature, thereby reducing stroke risk. Focus remains on cerebral protection technologies for surgical applications.
Who are the top competitors of Protembis?
Protembis's top competitors include Synaptive Medical, Emboline and Claret Medical.
What products or services does Protembis offer?
Protembis offers ProtEmbo Cerebral Protection System.
Who are Protembis's investors?
Protembis has 9 investors. Key investors include Abiomed, European Investment Bank, BMBF, Geratherm Medical AG, and Segulah Medical Acceleration.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.